Targeted Delivery of Panitumumab-Scaffold Bosutinib-Encapsulated Polycaprolactone Nanoparticles for EGFR-Overexpressed Colorectal Cancer
Nanomedicine · 2023
DOI: 10.2217/nnm-2022-0240 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nanomedicine, 2023. Verfasst von Sankha Bhattacharya und 11 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy & Technology Management, SVKM'S NMIMS Deemed-to-be University, Shirpur, Maharashtra, 425405, India. Hauptthemen laut MEDLINE: Nanoparticles, Colorectal Neoplasms, Colonic Neoplasms. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 64 Literaturangaben.
Abstract (Originalsprache)
Aims
Panitumumab (anti-Erb)-conjugated polycaprolactone (PCL) nanoparticles loaded with bosutinib (BTNB) were used to develop a targeted drug-delivery system for colon cancer cells. Materials & methods: Using carbodiimide coupling, anti-Erb was conjugated to BTNB-loaded PCL nanoparticles. Dynamic light scattering, scanning electron microscopy, transmission electron microscopy, Fourier-transform infrared spectroscopy, differential scanning calorimetry, x-ray diffraction and thermogravimetric analysis were used to analyze nanoparticles.
Results
According to in vitro studies, anti-Erb-BTNB-PCL nanoparticles inhibited HCT116 cells more than BTNB alone. Cell arrest at different phases was examined for apoptotic potential. An in vivo efficacy study showed that anti-Erb-BTNB-PCL nanoparticles could target tumors selectively.
Conclusion
Anti-Erb-conjugated BTNB nanoparticles could specifically target colon cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy & Technology Management, SVKM'S NMIMS Deemed-to-be University, Shirpur, Maharashtra, 425405, India.
- National Institute of Pharmaceutical Education & Research (NIPER), Industrial Area Hajipur, Distt: Vaishali, Bihar, 844102, India.
- Senior officer, Sun Pharma Laboratories LTD, Mirza-Palasbari road, Kamrup, Assam, 781128, India.
ORCID-Profile: Sankha Bhattacharya, Ketan Hatware, Mayank Sharma, Abhishek Kanugo, Datta Pawde, Saurabh Maru, Girdhari Lal Gupta
Zitieren
APA
Bhattacharya, S., Parihar, V. K., Singh, N., Hatware, K., Page, A., Sharma, M., Prajapati, M. K., Kanugo, A., Pawde, D., Maru, S., Gupta, G. L., & Kanvinde, S. (2023). Targeted Delivery of Panitumumab-Scaffold Bosutinib-Encapsulated Polycaprolactone Nanoparticles for EGFR-Overexpressed Colorectal Cancer. Nanomedicine. https://doi.org/10.2217/nnm-2022-0240
Vancouver
Bhattacharya S, Parihar VK, Singh N, Hatware K, Page A, Sharma M, et al. Targeted Delivery of Panitumumab-Scaffold Bosutinib-Encapsulated Polycaprolactone Nanoparticles for EGFR-Overexpressed Colorectal Cancer. Nanomedicine. 2023. doi:10.2217/nnm-2022-0240
BibTeX
@article{Bhattacharya2023,
author = {Bhattacharya, Sankha and Parihar, Vipan Kumar and Singh, Neeraj and Hatware, Ketan and Page, Amit and Sharma, Mayank and Prajapati, Mahendra Kumar and Kanugo, Abhishek and Pawde, Datta and Maru, Saurabh and Gupta, Girdhari Lal and Kanvinde, Sunil},
title = {Targeted Delivery of Panitumumab-Scaffold Bosutinib-Encapsulated Polycaprolactone Nanoparticles for EGFR-Overexpressed Colorectal Cancer},
journal = {Nanomedicine},
year = {2023},
doi = {10.2217/nnm-2022-0240}
}
EUVIMED